Factor IX deficiency, also known as Hemophilia B or Christmas disease, is a rare inherited bleeding disorder that prevents blood from clotting properly due to missing or defective clotting factor IX protein.

Epidemiology

Factor IX deficiency is the second most common type of hemophilia, though it remains a rare condition overall. This bleeding disorder occurs in approximately 1 in 25,000 male births in the United States, though estimates vary by region. In India, the incidence is estimated at 1 in 30,000 to 60,000 male births.^[1] Globally, Factor IX deficiency affects about 1 in 10,000 live male births.^[6]

The disorder affects males predominantly because of how it is inherited through the X chromosome. Hemophilia A, which involves a different clotting factor, is approximately seven times more common than Hemophilia B.^[1] Some sources indicate that Factor IX deficiency is four times less common than Factor VIII deficiency (Hemophilia A).^[6] All races and economic groups are affected equally by this condition, meaning no particular ethnic or socioeconomic group faces higher risk than others.^[1]

Approximately 20 percent of all hemophilia cases are classified as Hemophilia B, with Factor IX deficiency being the underlying cause.^[3] The condition can affect people across all ages, from newborns to adults, depending on the severity of their specific case. About half of individuals with Hemophilia B have factor IX levels greater than 1 percent of normal, which typically means milder symptoms.^[3]

Causes

Factor IX deficiency is caused by changes or mutations in the F9 gene, which contains the instructions for making clotting factor IX. This gene is located on the X chromosome, specifically in the region labeled Xq27.1-q27.2.^[6] When the F9 gene is altered, the body either produces too little factor IX or produces a version that does not work properly. Without adequate functional factor IX, the blood clotting process cannot proceed normally.

The disorder was originally named “Christmas disease” after Stephen Christmas, the first person diagnosed with this specific condition back in 1952.^[1][6] The name reflects a historical milestone in medical understanding, though the condition is now more commonly referred to as Hemophilia B or Factor IX deficiency in clinical settings.

Factor IX deficiency is inherited as an X-linked recessive disorder, meaning the genetic mutation is carried on the X chromosome and follows a specific inheritance pattern. Males have one X chromosome (from their mother) and one Y chromosome (from their father). If a male inherits an X chromosome carrying the mutated F9 gene, he will have the disease because he has no second X chromosome to compensate for the defective gene. Females have two X chromosomes, one from each parent. A female who inherits one mutated F9 gene typically becomes a carrier, meaning she has one working copy and one non-working copy of the gene. In most cases, the working copy provides enough factor IX to prevent symptoms, though approximately 30 percent of female carriers do have factor IX levels low enough to experience bleeding problems.^[14]

Family history is present in 60 to 70 percent of families affected by Hemophilia B, meaning the condition has been passed down through generations.^[6] However, in some cases, Factor IX deficiency occurs due to a new or spontaneous mutation. This means the genetic change happened for the first time during the development of the egg or sperm, or early in the embryo’s development. When this occurs, there is no family history of the disease, and the affected individual is the first in their family to have the condition. Some cases also result from somatic mosaicism, where the mutation is present in some cells but not others.^[6]

Risk Factors

The primary risk factor for developing Factor IX deficiency is having a family history of the disorder. Because the condition is inherited in an X-linked recessive pattern, males are at much higher risk of being affected than females. Any male who inherits an X chromosome carrying the mutated F9 gene from his mother will develop the bleeding disorder. This is why the disease almost always occurs in males, though rare cases can affect females under specific genetic circumstances.^[4]

Females can be carriers of the Factor IX deficiency gene and, while most carriers do not have symptoms, they can pass the mutated gene to their children. A carrier mother has a 50 percent chance of passing the mutated X chromosome to each of her children. If she has a son who inherits the mutated chromosome, he will have Hemophilia B. If she has a daughter who inherits the mutated chromosome, that daughter will also become a carrier.^[4]

If a father has Hemophilia B, he will pass his mutated X chromosome to all of his daughters, making them carriers. However, he will pass his Y chromosome to all of his sons, meaning none of his sons will inherit the disease from him (unless the mother is also a carrier or affected, which is extremely rare).^[19]

About 30 percent of heterozygous females—those who carry one mutated copy of the F9 gene—have factor IX clotting activity lower than 40 percent and are at risk for bleeding symptoms, even if the affected male family member has mild hemophilia B.^[14] In these cases, female carriers can experience prolonged or excessive bleeding after major trauma or invasive procedures, regardless of the severity level seen in male relatives. Women and girls who are carriers should inform their healthcare providers of their carrier status, especially before surgeries, dental procedures, or childbirth.

Symptoms

The symptoms of Factor IX deficiency vary widely depending on how much functional clotting factor IX is present in the blood. People with severe forms of the disorder experience frequent and sometimes spontaneous bleeding episodes, while those with mild forms may only notice problems after injuries or surgical procedures. The age at which symptoms first appear also depends on severity, with severe cases often diagnosed in infancy and mild cases sometimes not identified until adulthood.^[14]

In severe Factor IX deficiency, where factor IX levels are less than 1 percent of normal, symptoms usually become apparent within the first two years of life. Babies and young children may develop bumps and bruises easily, and parents may notice swelling or lumps on the child’s head after minor bumps.^[6] Without preventive treatment, individuals with severe hemophilia B may experience two to five spontaneous bleeding episodes each month. These bleeds often occur in joints such as the knees, elbows, and ankles, or in muscles, and can happen without any obvious injury or trauma.^[14]

Moderate Factor IX deficiency, where factor IX levels are between 1 and 5 percent of normal, typically presents in early childhood. Children with moderate hemophilia B usually experience prolonged or excessive bleeding after injuries or surgical procedures, including dental work. Some individuals with moderate disease also have spontaneous bleeding episodes, though less frequently than those with severe disease. The frequency of bleeding can range from once a month to once a year, depending on the individual and their activities.^[6]

Mild Factor IX deficiency, where factor IX levels are between 5 and 40 percent of normal, often goes undiagnosed until later in childhood or even adulthood. People with mild hemophilia B generally do not have spontaneous bleeding episodes. However, they experience abnormal bleeding during or after surgeries, dental extractions, or significant injuries if they do not receive treatment beforehand. The frequency of bleeding problems in mild cases may vary from once a year to once every ten years.^[14] In some cases, mild hemophilia B is only diagnosed after a tooth extraction, injury, or surgery when bleeding does not stop as expected.^[6]

Common symptoms across all severity levels include easy bruising, where even minor bumps can cause large, dark bruises to appear on the skin. Bleeding from the gums can occur spontaneously or during tooth brushing, and may be difficult to stop.^[1] Nosebleeds that are frequent and hard to stop are another common sign. People with Factor IX deficiency may notice blood in their urine or stool, which can indicate bleeding in the urinary or digestive systems. Bleeding into joints causes pain, swelling, and tightness, particularly in weight-bearing joints like the knees and ankles.^[19] Muscle bleeds can result in painful, swollen areas that hurt when touched.

A case report described a 32-year-old man who presented with gastrointestinal bleeding, vomiting, bloody vomit, and dark stools over a four-year period. These symptoms occurred intermittently, once or twice per month. He also experienced bleeding from his gums and easy fatigue. This case demonstrates that Factor IX deficiency can sometimes manifest with unusual or delayed symptoms, even in adulthood.^[1]

Bleeding into internal organs or the brain can be life-threatening and requires immediate medical attention. People with hemophilia may also experience delayed bleeding, where bleeding starts hours or even days after an injury, making it harder to connect the bleeding to a specific cause.^[19] Pain at injection sites after receiving shots, along with swelling or bleeding into muscles, is another symptom that parents of young children with Factor IX deficiency may observe.

Prevention

Because Factor IX deficiency is an inherited genetic condition, there is no way to prevent the disorder itself from occurring in someone who has inherited the mutated gene. However, there are important measures that can prevent bleeding episodes and their complications for people who have been diagnosed with the condition. Preventing bleeds is essential for maintaining quality of life, avoiding joint damage, and reducing the need for emergency medical care.

One of the most effective prevention strategies is prophylactic treatment, which means receiving regular infusions of factor IX replacement therapy to keep factor IX levels in the blood high enough to prevent spontaneous bleeding. For individuals with severe hemophilia B, and for those with moderate or mild forms who experience frequent bleeding, prophylactic treatment has been shown to prevent or significantly reduce the progression of joint damage.^[14][8] Prophylaxis is often started in early childhood, sometimes as early as one year of age, and can continue into adolescence and adulthood. Studies have demonstrated that starting preventive therapy early in childhood reduces the total number of bleeds and bleeding into joints, which in turn decreases overall joint deterioration and improves patients’ quality of life.^[8]

Physical activity is important for overall health and for maintaining muscle strength and joint health, which can help protect against bleeds. However, individuals with Factor IX deficiency should choose activities carefully and avoid contact sports or activities with high risk of injury. Low-impact activities such as swimming, walking, and certain forms of exercise recommended by physical therapists can help strengthen muscles without putting joints at excessive risk.^[16] Working with healthcare providers, including physical therapists experienced in bleeding disorders, can help individuals develop safe exercise plans tailored to their condition.

Education and awareness are critical components of prevention. People with Factor IX deficiency, their families, and caregivers should be educated about the signs of bleeding, when to seek medical attention, and how to administer factor replacement therapy at home if needed. Wearing medical alert identification, such as a bracelet or necklace, can inform emergency responders about the bleeding disorder in case of accidents or emergencies.

Certain medications should be avoided because they can increase bleeding risk. Nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin and ibuprofen interfere with platelet function and should generally not be used by people with bleeding disorders unless specifically approved by their healthcare provider. Before taking any new medication, including over-the-counter drugs or supplements, individuals should consult their doctor or hemophilia treatment center.

Regular follow-up care at a comprehensive hemophilia treatment center is essential for monitoring the condition, adjusting treatment plans, and addressing any complications early. These specialized centers provide multidisciplinary care with hematologists, nurses, physical therapists, social workers, and other professionals who understand bleeding disorders.^[9] Patients treated at comprehensive care clinics have been shown to have better access to care, less morbidity, and better overall outcomes.^[8]

For families with a history of Factor IX deficiency, genetic counseling can provide information about the risk of passing the condition to future children. Carrier testing is available for females who may carry the mutated gene, and prenatal testing options exist for pregnant women who are known carriers or who have a family history of the disorder.^[14] These services help families make informed decisions and prepare for the care their child may need.

Pathophysiology

Understanding how Factor IX deficiency affects the body’s normal blood clotting process helps explain why people with this condition experience prolonged or excessive bleeding. Blood clotting is a complex series of events known as the clotting cascade, where multiple proteins work together in a specific sequence to form a stable blood clot that stops bleeding after an injury.

When a blood vessel is damaged, the first response is the formation of a temporary plug made of small cell fragments called platelets. Platelets rush to the site of injury and stick together, but this initial plug is unstable and needs reinforcement to effectively stop bleeding.^[19] This is where clotting factors, including factor IX, play their crucial role.

The clotting cascade involves a series of proteins that become activated in sequence. Factor IX is activated and works together with activated factor VIII (which is deficient in Hemophilia A) to activate another protein called factor X. Once factors VIII, IX, and X are activated, they work together to generate thrombin, a key enzyme necessary for forming a stable clot. Thrombin helps create a mesh of protein fibers called fibrin that spreads over the platelet plug, binding the platelets together into a strong, stable clot that can effectively stop bleeding.^[19]

In people with Factor IX deficiency, the lack of functional factor IX disrupts this cascade. Without enough working factor IX, the activation of factor X is impaired, which means less thrombin is generated. With insufficient thrombin, the fibrin mesh cannot form properly, and the blood clot remains weak and unstable. This explains why people with Factor IX deficiency experience prolonged oozing after injuries, delayed bleeding, or bleeding that recurs before wounds are fully healed.^[14]

The severity of bleeding symptoms directly relates to how much functional factor IX is present in the blood. Normal factor IX levels range from 50 to 200 percent of average activity. When levels fall below 40 percent, symptoms of the disease begin to appear. In severe Factor IX deficiency, where less than 1 percent of normal factor IX is present, the clotting cascade is severely impaired, leading to frequent spontaneous bleeding episodes.^[6] In mild cases, where 5 to 40 percent of factor IX is present, the clotting process works well enough to prevent spontaneous bleeds but fails under the stress of surgery, injury, or dental procedures.

Laboratory tests used to diagnose Factor IX deficiency reflect these disruptions in the clotting cascade. The activated partial thromboplastin time (aPTT) measures how long it takes for blood to clot through the pathway that involves factors VIII and IX. In people with Factor IX deficiency, the aPTT is prolonged because the clotting cascade is slowed down.^[1] Other clotting tests, such as prothrombin time (PT), which measures a different clotting pathway, typically remain normal in Hemophilia B. Specific factor assays measure the actual level of factor IX activity in the blood and confirm the diagnosis.^[6]

Bleeding in Factor IX deficiency typically occurs in specific locations. Joint bleeds, called hemarthroses, are common and particularly problematic because repeated bleeding into joints can lead to chronic joint damage, pain, and disability over time. Muscle bleeds can cause swelling, pain, and temporary loss of function in the affected area. Bleeding can also occur in the digestive tract, urinary tract, and, in severe cases, the brain, which can be life-threatening.^[6]